000 02965nam a22003377a 4500
008 240723s20242024 xxu||||| |||| 00| 0 eng d
022 _a2701-0198
040 _aOvid MEDLINE(R)
099 _a38419396
245 _aExploring the Impact of TLR-2 Signaling on miRNA Dysregulation in Intervertebral Disc Degeneration.
251 _aAdvances in Biology Online. :e2300581, 2024 Feb 28
252 _aadv. biol. :e2300581, 2024 Feb 28
253 _aAdvanced biology
260 _c2024
260 _p2024 Feb 28
265 _saheadofprint
265 _tPublisher
266 _d2024-07-23
520 _aToll-like receptors (TLRs) are key mediators of inflammation in intervertebral disc (IVD) degeneration. TLR-2 activation contributes to the degenerative process by increasing the expression of extracellular matrix-degrading enzymes, pro-inflammatory cytokines, and neurotrophins. As potent post-transcriptional regulators, microRNAs can modulate intracellular mechanisms, and their dysregulation is known to contribute to numerous pathologies. This study aims to investigate the impact of TLR-2 signaling on miRNA dysregulation in the context of IVD degeneration. Small-RNA sequencing of degenerated IVD cells shows the dysregulation of ten miRNAs following TLR-2 activation by PAM2CSK4. The miR-155-5p is most significantly upregulated in degenerated and non-degenerated annulus fibrosus and nucleus pulposus cells. Sequence-based target and pathway prediction shows the involvement of miR-155-5p in inflammation- and cell fate-related pathways and TLR-2-induced miR-155-5p expression leads to the downregulation of its target c-FOS. Furthermore, changes specific to the activation of TLR-2 through fragmented fibronectin are seen in miR-484 and miR-487. Lastly, miR-100-3p, miR-320b, and miR-181a-3p expression exhibit degeneration-dependent changes. These results show that TLR-2 signaling leads to the dysregulation of miRNAs in IVD cells as well as their possible downstream effects on inflammation and degeneration. The identified miRNAs provide important opportunities as potential therapeutic targets for IVD degeneration and low back pain. Copyright © 2024 The Authors. Advanced Biology published by Wiley-VCH GmbH.
546 _aEnglish
650 _zAutomated
650 _aIN PROCESS -- NOT YET INDEXED
651 _aMedStar Washington Hospital Center
656 _aOrthopedic Surgery
657 _aJournal Article
700 _aMesfin, Addisu
_bMWHC
790 _aCazzanelli P, Lamoca M, Hausmann ON, Mesfin A, Puvanesarajah V, Hitzl W, Haglund L, Wuertz-Kozak K
856 _uhttps://dx.doi.org/10.1002/adbi.202300581
_zhttps://dx.doi.org/10.1002/adbi.202300581
858 _yCazzanelli, Petra
_uhttps://orcid.org/0009-0007-3114-951XI - Wuertz-Kozak, Karin
_uhttps://orcid.org/0000-0002-3281-4629
_zhttps://orcid.org/0009-0007-3114-951XI - Wuertz-Kozak, Karin
_zhttps://orcid.org/0000-0002-3281-4629
942 _cART
_dArticle
999 _c14223
_d14223